Oct 29, 2021 / 05:00AM GMT
Presentation
Oct 29, 2021 / 05:00AM GMT
=====================
Corporate Participants
=====================
* Bernhardt G. Zeiher
Astellas Pharma Inc. - Chief Medical Officer & President of Development
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Representative Director
* Naoki Okamura
Astellas Pharma Inc. - Executive VP, CFO, Chief Strategy Officer, Chief Business Officer & Representative Director
* Yukio Matsui
Astellas Pharma Inc. - Chief Commercial Officer & Senior Corporate Executive
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research
Astellas Pharma Inc
(OTCPK:ALPMF)
$
11.1275
0 (0%)
Market Cap: 20.04 Bil
Enterprise Value: 23.95 Bil
PE Ratio: 56.39
PB Ratio: 2.01
GF Score: 87/100 Q2 2022 Astellas Pharma Inc Earnings Presentation Transcript
Oct 29, 2021 / 05:00AM GMT
Release Date Price:
$16.41
(-3.47%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot